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ABSTRACT
Blood Oxygen Level Dependent (BOLD) fMRI is a common technique for measuring brain 
activation that could be affected by low-level carbon monoxide (CO) exposure from e.g. smoking. 
This study aimed to probe the vulnerability of BOLD fMRI to CO and determine whether it may 
constitute a significant neuroimaging confound. Low-level (6ppm exhaled) CO effects on BOLD 
response were assessed in 12 healthy never-smokers on two separate experimental days (CO 
and air control). fMRI tasks were breath-holds (hypercapnia), visual stimulation and fingertapping. 
BOLD fMRI response was lower during breath holds, visual stimulation and fingertapping in the 
CO protocol compared to the air control protocol. Behavioural and physiological measures 
remained unchanged. We conclude that BOLD fMRI might be vulnerable to changes in baseline 
CO, and suggest exercising caution when imaging populations exposed to elevated CO levels. 
Further work is required to fully elucidate the impact on CO on fMRI and its underlying 
mechanisms.
Keywords: BOLD, carbon monoxide, fMRI, physiological confounds, smoking
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1. INTRODUCTION
One of the most common methods used to measure brain function in humans is fMRI, of which 
Blood Oxygen Level Dependent (BOLD) fMRI is arguably the most mainstream technique. BOLD 
fMRI is an indirect measure of brain activation, based on changes in the ratio of oxygenated to 
deoxygenated blood in the brain, which depends on cerebral metabolic rate (CMRO2), cerebral 
blood volume (CBV) and cerebral blood flow (CBF) 1. These factors may be altered as part of the 
experimental design or as unintended confounds, potentially affecting BOLD response.
Carbon monoxide (CO) is a toxic gas that can act as a cerebral vasodilator 2, 3. Increases in CBF 
with elevations in CO have been shown in animal models 3-7 as well as in humans 8, 9. Low-level 
CO exposure is common, through inhalation of cigarette smoke or air pollution. Due to its high 
affinity for haemoglobin, CO immediately enters and can linger in the bloodstream for several 
hours after inhalation. Smokers typically have persisting elevated levels of CO bound to 
haemoglobin in their blood (carboxyhaemoglobin, COHb), which is reflected in higher exhaled 
levels of CO (6ppm in exhaled air or above 10) compared to non-smokers (1-5ppm). As smoking 
behaviour is associated with e.g. socioeconomic status and disease status, elevated COHb may 
significantly influence neuroimaging results on the group level in certain demographic groups. For 
example, if low-level CO causes a baseline increase in CBF, this might affect fMRI outcome as 
the BOLD response for any given task is assessed by comparing task-related signal to baseline 
signal. An increased baseline could artificially dampen or alter the time course of the observed 
task-specific BOLD response 11-13. To our knowledge, the effect of CO on fMRI signal has not 
been investigated in previous studies, except as part of cigarette smoking, where its impact is 
confounded by other (vasoactive) tobacco components. The rationale for this study was to test if 
CO could alter BOLD fMRI response in response to three different fMRI tasks.
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One method to test cerebral vascular function is carbon dioxide (CO2) exposure. Hypercapnia 
induces a strong CBF increase 14, and has often been used as a cerebrovascular challenge in 
fMRI studies 11, 15-17 due to its global and reproducible effect on BOLD response 16, 18. Raising 
baseline CBF by CO2 inhalation can furthermore reduce or cause delays or non-linearity in the 
vascular responsiveness to subsequent hypercapnia 11, 12. In this study, we therefore used 
hypercapnia derived through breath holds as a tool to investigate the effect of CO on BOLD 
response, as it is a robust, reproducible stimulus, and susceptible to changes in baseline CBF. 
We hypothesised that low-level CO inhalation would significantly reduce global BOLD response 
during hypercapnia. To determine whether the effect of CO extended to common fMRI paradigms, 
we also included a simple visual stimulation and motor task, hypothesising that CO would dampen 
BOLD response in brain regions associated with these tasks.
2. MATERIALS AND METHODS
2. 1 Participants
We recruited 12 (8F, age 25.3+/-4.3 years) healthy never-smokers to the study. Never smokers 
were chosen to ensure a uniform sample group as smokers typically have varying levels of COHb 
and may exhibit variation in e.g. craving. Exclusion criteria were MRI contraindications, smoking 
history, history of cardiorespiratory or neurological disease, and pregnancy. Female participants 
were on hormonal contraceptives. All participants gave written, informed consent. The study was 
approved by Oxford Brookes University Research Ethics Committee (approval number 140840) 
and carried out in accordance with the Declaration of Helsinki. The sample size was determined 
by a formal statistical power calculation (fMRIpower software package, www.fmripower.org 19). At 
alpha level 0.05, 11 subjects were found to provide at least 80% power to detect an effect. Twelve 
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were recruited to ensure that the study was powered in case of any unforeseen events (e.g. 
subject dropout).
2.2 Protocol
Participants were asked to attend a preliminary laboratory visit. During this visit, medical history 
and state and trait anxiety inventory (STAI) questionnaires were completed 20. A CO inhalation 
test was conducted to let the participant familiarise themselves with the breathing system and the 
CO exposure. Participants were asked to breathe on a custom-made breathing system through a 
mouthpiece with their nose occluded, and were given time for their breathing to stabilise before 
commencing the experiment. A full description of the breathing system can be found in the 
supplement. After stable breathing had been recorded for five minutes, CO was added to the 
inspired air over five minutes, out of sight of the participant. Following CO administration, five 
more minutes of stable breathing was recorded. During the experiment, ECG, pulse pressure and 
saturation was continuously measured. Expired CO was measured before, immediately after, and 
10 minutes after the breathing test (Micro+ Smokelyzer, Intermedical Ltd., Kent). The Smokelyzer 
kit is suitable for non-invasive, repeated assessments of expired CO in humans, and its output 
was compared with COHb values (blood samples) prior to the study to ensure correct readings.
MRI scans were conducted on two separate days (Figure 1). Participants were asked to complete 
the state anxiety part of STAI on arrival and no more than 15 minutes after the end of the 
experiment on each day. Whilst in the scanner, participants were asked to undertake the following 
tasks: breath holds, a visual stimulation task, a motor task and a simple reaction time task. Breath 
holds were conducted end-expiration, signalled by visual cues and lasting 15 seconds. 
Participants were instructed to follow each breath-hold with an expiration (rather than inspiration) 
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to obtain accurate end-tidal PCO2 values. The visual stimulation was a flashing checkerboard 
(8Hz, lasting 10 seconds). The motor task was tapping of the right index finger, signalled by visual 
cues and lasted 15 seconds. The reaction time task required participants to immediately press a 
button upon the appearance of a red dot on the screen (24 appearances, random intervals). 
These tasks were conducted twice, once before the breathing intervention (baseline) and once 
after (post-intervention). The participants received the gas mixtures in the scanner, and their head 
was kept in the same position for the intervention and subsequent scan. On one day, the 
intervention was air, and on the other day, the intervention was CO. Participants were not aware 
of which intervention would be given on any of the days and the order of the interventions was 
randomised and balanced. Participants were asked verbally after each protocol if they felt any 
change in their breathing, and if they could guess which protocol they had undertaken. Training 
in all fMRI tasks were given by an experimenter prior to the first scan on each day, to ensure that 
the participant could reliably complete these on their own in the scanner. Expired CO 
measurements were made before the first scan, immediately after the second scan (~20 minutes 
after the breathing intervention) and 10 minutes after the second scan (~30 minutes after the 
breathing intervention). An extended protocol section can be found in the supplement. 
2.3 MRI data acquisition 
Imaging was performed at the University of Oxford Centre for Clinical Magnetic Resonance 
Research with a Siemens 3Tesla TIM-Trio scanner, using a 12-channel head coil. Participants 
were given two fMRI scans (BOLD echo-planar image acquisition, time repetition (TR) = 3000ms, 
time echo (TE) = 30ms, field-of-view = 192x192mm, voxel-size = 3x3x3mm, 45 slices) on each 
day, separated by the intervention period (air or CO). A structural T1-weighted, whole-brain scan 
(MPRAGE, TR = 2040ms, TE = 4.7ms, flip angle = 8°, voxel-size = 1x1x1mm) was collected and 
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used for image registration.
Heart rate (HR) and pulse oximetry (SaO2, multigas monitor, 9500, MR Equipment), ECG, 
respiration (respiratory bellows around the chest) and end-tidal partial pressures of oxygen 
(PETO2) and CO2 (PETCO2; Datex, Normocap) were continuously measured throughout the scans. 
ECG data were observed throughout. All other physiological data were sampled at 50Hz and 
recorded along with scan volume triggers via PowerLab 16/35 using LabChart (ADinstruments).
2.4 Data Analysis
fMRI data processing was carried out within FSL (Oxford Centre for Functional Magnetic 
Resonance Imaging of the Brain (FMRIB) Software Library), using FEAT (FMRI Expert Analysis 
Tool) Version 6.0. The cluster Z threshold was set to 3.1 and a corrected cluster significance 
threshold to p=0.05. 
Prestatistic processing of the data included MCFLIRT motion correction 21, spatial smoothing with 
a full-width-half-maximum Gaussian kernel of 5mm and high-pass temporal filtering (Gaussian-
weighted least-squares straight line fitting, high-pass filter cut-off of 60s). FSL motion outliers 
(https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FSLMotionOutliers) was used to detect and regress out large 
motion artifacts. Data were modelled using FMRIB’s Improved Linear Model (FILM) with local 
autocorrelation correction 22. Images were registered to the MNI152 standard space using an 
affine registration between the EPI and T1-weighted scan and a nonlinear registration between 
the T1-weighted scan and the MNI standard brain.
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General Linear Models (GLMs) with multiple explanatory variables (EVs) incorporating timing 
values for the different events were designed to describe the data. The haemodynamic response 
function (HRF) was modelled using a standard gamma waveform. A physiological noise modelling 
tool was used to regress out effects of physiological noise 23. A 6-second haemodynamic delay 
was assumed and contrast images were used for higher-level analyses as appropriate. An end-
tidal CO2 regressor was used to analyse the BOLD response change associated with the breath-
hold challenge. This was done by extracting the breath by breath PETCO2 data and convolving 
this with an HRF (e.g. see 24). This approach models the breath hold challenge response with the 
recorded PETCO2 values and thus makes no assumption about breath-hold length. This analysis 
fits the signal to the PETCO2 data and returns statistical maps of significant changes in BOLD 
response (thresholded zstats). These statistical maps were also converted to %BOLD/mmHg CO2 
in a second, separate analysis of cerebrovascular reactivity (CVR). 
A fixed-effects model was used to generate contrast of parameter estimate (COPE) images of the 
mean signal for all scans as well as the difference between the baseline and post-intervention 
scans for each participant on each experimental day. The baseline vs post-intervention difference 
COPE images were calculated to compensate for any variation in baseline between days and 
account for potential test-retest variability. This was done by forcing random effects variance to 
zero in FLAME (FMRIB’s Local Analysis of Mixed Effects) 25, 26. 
Voxelwise statistical analysis was extended to a group level, in a mixed-effects analysis using 
FLAME 26 with automatic outlier de-weighting, and Z statistic images were thresholded using 
clusters determined by Z > 3.1 and a p < 0.05 (corrected) cluster significance threshold. Means 
of COPE images were calculated for all conditions. Group analyses compared COPE images 
between protocols for each task using a whole-brain approach, and with the following contrasts 
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of interest: PETCO2 values with breath holds, presentation of flashing checkerboards (visual task) 
and finger-tapping. An analysis using the older standard of a 2.3 cluster-forming threshold was 
also conducted, and is included in the Supplement.
STAI questionnaires were scored according to their respective manuals and compared using 
paired nonparametric t-tests (Mann-Whitney U test). Reaction times were averaged for each 
participant and compared using Student’s t-test (paired). Physiological data were analysed using 
custom-written MATLAB scripts and compared using Student’s t-tests (paired). Data obtained 
during the motor task were used for comparison of end-tidal gases between protocols.
3. RESULTS
3. 1 Psychological and physiological data
There were no significant differences between protocols in anxiety scores (t(11)=0.61, p=0.55) or 
reaction times (t(23)=1.1, p=0.29). None of the participants was able to discern between CO and 
air inhalations, nor did they report any change in breathing. PETO2 was reduced between baseline 
and post-intervention scans in both protocols, but no significant difference was found between 
protocols (t(11)=-0.58, p=0.57). There was no change in PETCO2 or HR between scans or 
protocols. CO values increased significantly in the CO protocol (p<0.0001, Figure 2), but not air 
(p=0.10). COHb values (estimated from exhaled CO) also showed a significant increase in the 
CO protocol (P<0.0001, Table 2), but not air. The modest rise in COHb (from 1.1%+/-0.1 to 
1.5%+/-0.2) highlights the low level of CO used in the study. Participant details are shown in Table 
1, and physiological data in Table 2. Extended participant demographics and physiological data, 
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including PETCO2 and PETO2 averages and CO2 traces for all tasks, can be found in the 
supplement.
3. 2 fMRI data
For fMRI results, significance denotes thresholded, cluster corrected, signal (cluster-forming 
threshold of 3.1, p<0.05)27.
Breath hold task (Figure 3). The rise in CO2 with breath holds caused BOLD response change 
(increase) throughout the grey matter during all scans. Figure 3 shows pre-intervention and post-
intervention BOLD response for both air and CO protocols, and group (protocol) contrasts 
between the pre- versus post-intervention difference maps. These Z score maps indicate a 
significant linear regression of the end-tidal CO2 and BOLD response, as expected with rises in 
PETCO2. This was seen for the control protocol and the baseline scan (pre) for the CO protocol, 
but not after CO inhalation. Following CO inhalation, activation was significantly reduced in the 
left insula, premotor cortex, left secondary somatosensory cortex and in the brain stem (see 
Supplement Figure S6). Group comparisons showed lower significant BOLD response change in 
the CO protocol compared to air in the left operculum and insula. 
CVR maps for the breath hold task can be found in the supplement (Figure S5). Statistical 
comparisons showed no difference in mean %BOLD/mmHg between baseline (pre-intervention) 
scans, but a statistically significant difference in post-intervention scans (CVR lower in the CO 
protocol, p=0.048). 
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Visual task (Figure 4). The flashing checkerboard generated significant BOLD activation in the 
visual cortex for all scans. Group comparisons showed lower activation in response to the task in 
the CO protocol compared to air. This was observed in the visual cortex. 
Motor task (Figure 5). The finger-tapping task generated significant task-related BOLD activation 
in the left primary and secondary somatosensory cortices, the left premotor and primary motor 
cortices, the left thalamus and the visual cortex for all scans. Group comparisons showed lower 
activation in response to the task in the CO protocol compared to air in the visual cortex. The 
group analysis at a lower cluster-forming threshold also showed higher activation in the CO 
protocol compared to air in the premotor cortex (Figure S10). 
4. DISCUSSION
4. 1 Key findings
In this study we show that a small amount of inhaled CO, raising expired levels from ~3ppm to 
~6ppm, significantly alters BOLD response in never-smokers. This suggests that CO, even in low 
doses, might be a confound in BOLD fMRI. Systematic differences in COHb between e.g. a 
patient group consisting of a greater proportion of smokers and a control group of predominantly 
non-smokers could generate group differences that are CO-related rather than associated with 
the specific research outcome. This could affect the results of clinical trials and patient-oriented 
neuroscience research. Given that absolute measures of CBF were not obtained in this study, the 
mechanism underlying the observed impact remain unknown (although potential mechanisms are 
discussed below). Future studies should incorporate flow measurements using techniques such 
as Arterial Spin Labelling to further elucidate the effect of CO on BOLD fMRI.
Page 11 of 30Journal of Cerebral Blood Flow and Metabolism
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
4. 2 Discussion of findings
Studies have shown that global baseline increases in CBF can reduce or alter task-related BOLD 
response. For example, Cohen et al 28 used experimentally induced hypercapnia to reduce visual 
activation, and Brown et al 29 showed that the cerebral vasodilator acetazolamide can dampen 
motor activation. Similarly, Halani et al 11 showed that BOLD response could be modulated by 
changes in baseline CBF (induced by hypercapnia) as this altered the time course of 
cerebrovascular responses. Yet this effect has not yet been linked to CO exposure. 
To probe the vulnerability of the BOLD response to COHb elevation, we employed a low-level 
increase in inhaled CO, raising exhaled levels to the lowest associated with tobacco smoking. 
Using this minimal level, we observed significant effects on BOLD response during a hypercapnic 
challenge and during commonly used visual and motor tasks. The large impact of low-level CO 
exposure on common fMRI paradigms such as a simple flashing checkerboard and finger-tapping 
tasks highlights the relevance of the present findings. 
The effect of CO on BOLD response was not uniform. BOLD response changes associated with 
visual and motor tasks were impacted by CO exposure. Compared to air, the BOLD response 
changes were lower for the visual task and lower in the visual cortex during the motor task, but 
analysis using a lower cluster-forming threshold of 2.3 also showed an area of activation in the 
motor cortex that was higher compared to air during the motor task (see Figure S10). The 
reduction in visual cortex signal mirrors that for the visual task, and may be associated with the 
visual instructions on screen throughout tapping intervals. The agreement in CO-impact on BOLD 
response in the visual cortex between these two separate and different tasks is encouraging. 
However, the higher BOLD response in the motor cortex after CO exposure compared to after 
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air, despite only surviving at a lower cluster-forming threshold (Figure S10, S11), could indicate 
that the impact of CO on global fMRI signal might be complex. Studies have shown that 
hypercapnia may affect BOLD response differently depending on the type of task and activated 
brain regions. For example, Kastrup et al. 30 reported that BOLD response changes with 
hypercapnia were greater in the visual cortex than in the sensorimotor cortex, possibly due to the 
location of large veins and/or neural activity associated with respiratory stimuli 31. Bright et al 12 
have shown that there are regional differences in optimal haemodynamic delay under 
hypercapnic conditions, with the visual cortex trending towards lower optimal delay than e.g. the 
parietal lobe. It is possible that the regional variations observed in our study is, in part, due to 
variations in optimal haemodynamic delay although further studies are required to fully elucidate 
the underlying mechanism. 
4. 3 Potential mechanisms
At present, we cannot be certain of the mechanism(s) underlying CO mediation of BOLD 
response. Acute CO exposure can cause cerebral vasodilation both directly 32 and indirectly 
through nitric oxide 33, and changes in CBF can impact BOLD response in a variety of ways34. 
Increases in baseline CBF can create ceiling effects, thus reducing task-related signal 34. For 
example, hypercapnia has been shown to increase baseline CBF, reduce BOLD activation 28, 34 
and alter the time course of the BOLD response 11, 12 in a potentially region-specific manner 12. 
While it is difficult to draw direct comparisons between hypercapnia and CO exposure, particularly 
during breath holds as CO and CO2 may interact 35, it is possible that similar mechanisms underlie 
our findings. Hypercapnia has also been shown to reduce CVR 13 (but see also 12). Indeed, we 
observed that CVR following CO inhalation was significantly reduced compared to CVR following 
air inhalation, suggesting that CO may affect BOLD response at least partly through changes in 
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CVR. In summary, both alteration of the BOLD response time course and changes in CVR may 
explain the impact of CO on BOLD response in our study.
Other mechanisms that may contribute to the observed BOLD response change include the 
formation of COHb at the expense of oxyhaemoglobin. This may cause increased CBF through 
the development of hypoxia 36, and may be augmented by the presence of hypercapnia 35. While 
we observed reduced PETO2 during the second scan on each experimental day, this was similar 
for both protocols, and may thus rather be due to altered breathing patterns during the 
experimental protocol despite pre-scan acclimatization to the breathing system. Furthermore, 
PETO2 remained within normal range throughout the experiment. It is therefore unlikely that 
hypoxia is the cause of the observed group differences. Hypoxia may, however, contribute to 
BOLD response changes at higher doses of CO. Another way in which CO could reduce BOLD 
response is by shifting the oxygen dissociation curve to the left, reducing oxygen availability. 
While this is unlikely to be the mechanism in the present study, given the low levels of COHb 
observed, the impact of CO on physiology is complex and should not be ignored.
CO may also slightly inhibit cell respiration even under normoxic conditions 37 and it remains 
unknown whether the observed effect on BOLD response is linked in part to metabolic modulation. 
Similarly, we cannot rule out the possibility that CO altered BOLD response through its role as an 
endogenous neurotransmitter 38. 
Participants showed no change in reaction times with CO compared to air, no difference in anxiety 
scores, and were not able to tell which protocol they were undertaking when prompted. It is thus 
unlikely that the effect on BOLD response observed in our study is driven by behavioural factors. 
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While further work is required to elucidate the precise mechanism underlying our findings, it is 
clear that CO can alter BOLD response, and should be considered a non-negligible neuroimaging 
confound. Further work should include formal comparisons between smokers and non-smokers 
to determine the impact of CO on BOLD response in a wider population beyond our tightly-
controlled sample.
4. 4 Brain regions
As the purpose of the study was to assess whether there is an overall, global effect of CO on 
BOLD response rather than interrogating specific neural responses, tasks were not linked to 
behavioural measures. Consequently, the following interpretation of BOLD response change 
patterns is speculative in nature as it relies upon reverse inference, and will be kept short. We 
observed BOLD response reductions after CO for the visual task in the visual cortex (as expected 
for this task), although this was not found in the contrast between protocols. The BOLD response 
change outside of the visual cortex was not significant in either mean analysis, suggesting that 
protocol differences were driven by small variations in signal between protocols (see e.g. 39). 
Similarly, group analysis showed reduced BOLD response change in response to the breath hold 
task in the left insula, which is associated with breathing challenges and anticipation of the same39-
42. Mean contrasts also highlighted differences in the premotor cortex, left secondary
somatosensory cortex, left supramarginal gyrus 39, 40 and in the brain stem 40, 43. The reason for 
the lateralisation remains unknown, but may be due to left-lateralisation associated with reading 
44. It is thus possible that there are effects of CO on BOLD response that are specific to respiratory
processing centres, and that tasks probing such regions could be particularly susceptible to CO 
effects, although further studies incorporating appropriate behavioural measures are required to 
determine if this is the case. 
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4. 5 Implications for neuroimaging and clinical trials
In this study, we show that low-level CO exposure may significantly alter BOLD response. Due to 
its affinity for haemoglobin, CO is not readily removed and therefore its effects on signal could 
persist for some time following inhalation. Here, CO assessments made following the scan 
(approximately 20 and 30 min after the intervention) show steady, elevated levels of exhaled CO 
(Figure 2). This level of CO exhalation is at the lower end of that associated with smokers, with 
mean exhaled values being more than 20ppm in outpatient groups 10. It remains unknown if higher 
levels of CO exposure will have a greater effect (i.e. a dose-dependent effect similar to that 
observed in rat aortas 45). Furthermore, the findings observed in this paper suggest that the effect 
may be region- and/or task-dependent, which could complicate any potential adjustments for 
COHb during analysis.   
Smoking is associated with a range of diseases, including cardiorespiratory diseases, cancers, 
dementia and cognitive decline 46 and several mental disorders 47, as well as demographic factors 
such as socioeconomic status, education and income level 48. CO exposure through cigarette 
smoking could therefore constitute a significant confound in neuroimaging research. Differences 
in COHb may occur both longitudinally (e.g. if smoking participants or patients are encouraged to 
stop smoking) and whenever participants or patients are compared with controls that are not 
precisely matched for smoking behaviour. Furthermore, the possibility for dose-dependent effects 
means that it may not be sufficient to match simply for ‘smoker’ and ‘non-smoker’, but rather the 
amount of COHb present in the blood stream. Given that only a small increase in COHb might 
affect BOLD response, this confound should be monitored carefully, particularly in clinical trials. 
4.6 Conclusions 
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We conclude that even small amounts of inhaled CO might significantly alter BOLD response 
during simple tasks such as breath hold, visual stimulation and finger-tapping. Further research 
is required to assess the precise underlying mechanism of this effect as well as generalisability 
to a wider population including smokers. We suggest that care should be taken to include CO as 
a potential confound in neuroimaging research when appropriate, for example in studies on 
clinical populations with greater/lower prevalence of smokers.   
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FIGURE LEGENDS
Figure 1. Schematic of protocol. fMRI tasks included breath holds (T1), visual stimulation (8Hz 
flashing checkerboard, T2) and a (right hand) finger tapping task (T3). Two sets of BOLD scans 
(each 10 min 6 s) were obtained on each experimental day, separated by a 5 min breathing 
intervention (air or CO, order randomized and counterbalanced) during which a structural scan 
was acquired.
Figure 2. Exhaled CO (ppm). Baseline, post-scan (~20 min after end-inhalation) and 10 min 
post-scan (~30 min after end-intervention). Individual values plus average and standard deviation 
(bold line). 
Figure 3. BOLD fMRI response associated with breath-by-breath end-tidal CO2 during the 
breath hold task.  Whole-brain analysis. Images are colour-rendered statistical maps (Z scores) 
superimposed on a standard (MNI) brain. Significant regions are displayed with a threshold of 
Z>2.3 with a cluster probability threshold of p<0.05 (corrected for multiple comparisons). Maps 
are BOLD response associated with air and CO inhalation (pre- and post-intervention), pre versus 
post-intervention difference maps for each protocol (), and contrasts between protocols (contrast 
between the pre- versus post-intervention difference maps). For contrasts, blue-lightblue 
indicates where BOLD response following CO (i.e. CO(post>pre)) was lower than BOLD response 
following air – i.e. on the day the participants inhaled CO, the BOLD response was reduced in the 
post-inhalation scan, but this did not occur on the day the participants inhaled Air. This difference 
between protocols was significant. In no area was BOLD response following CO increased 
compared to BOLD response following Air. A shows areas where change in BOLD fMRI response 
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for the CO protocol correlates with individual rise in CO level. Red-yellow indicates a positive 
correlation.
Figure 4. BOLD fMRI response during visual stimulus. Whole-brain analysis. Images are 
colour-rendered statistical maps superimposed on a standard (MNI) brain. Significant regions are 
displayed with a threshold of Z>2.3 with a cluster probability threshold of p<0.05 (corrected for 
multiple comparisons). Maps are BOLD response associated with air and CO inhalation (pre- and 
post-intervention), pre versus post-intervention difference maps for each protocol (), and 
contrasts between protocols (contrast between the pre- versus post-intervention difference 
maps). For contrasts, blue-lightblue indicates where BOLD response following CO (i.e. 
CO(post>pre)) was lower than BOLD response following air – i.e. on the day the participants 
inhaled CO, the BOLD response was reduced in the post-inhalation scan, but this did not occur 
on the day the participants inhaled Air. This difference between protocols was significant. In no 
area was (CO(post>pre)) greater than (Air(post>pre).
Figure 5. BOLD fMRI response during motor task. Whole-brain analysis. Images are colour-
rendered statistical maps superimposed on a standard (MNI) brain. Significant regions are 
displayed with a threshold of Z>2.3 with a cluster probability threshold of p<0.05 (corrected for 
multiple comparisons). Maps are BOLD response associated with air and CO inhalation (pre- and 
post-intervention), pre versus post-intervention difference maps for each protocol (), and 
contrasts between protocols (contrast between the pre- versus post-intervention difference 
maps). For contrasts, blue-lightblue indicates where the BOLD response following CO (i.e. 
CO(post>pre)) was lower than the BOLD response following air and red-yellow indicates where 
the BOLD response following CO was greater than the BOLD response following air.
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Table 1. Participant details and behavioural data. Mean(SD). Range included for STAI scores. 
BMI = body mass index, RT = reaction time.
preliminary visit MRI visit (CO) MRI visit (Air)
Sex (F/M) 8/4 8/4 8/4
Age (years) 25.3 (4.3) 25.3 (4.3) 25.3 (4.3)
BMI (kg/m2) 23.6 (3.0) 23.6 (3.0) 23.6 (3.0)
Trait anxiety score 35.4 (7.2) [23-47] N/A N/A
State anxiety score 31.1 (8.6) [21-55] 27.0 (4.3) [21-35] 28.2 (4.4) [23-37]
RT change (post > pre) N/A 15.2 (24.3) 10.0 (21.8)
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Table 2. Physiological data. Mean(SD). PETCO2, PETO2 and HR obtained during visual 
stimulation task. CO obtained pre-MRI and post-MRI (20-25 min after CO delivery). 
Estimated COHb included. Paired t-tests within visit *p<.05, **p<.01, ***p<.0001. 
MRI visit (CO) MRI visit (Air)
Baseline Post-intervention Baseline Post-intervention
PETCO2 (%) 5.5 (0.7) 5.5 (0.7) 5.3 (0.7) 5.4 (0.7)
PETO2 (%) 15.5 (1.2) 15.0 (0.9)* 15.5 (0.7) 14.9 (0.7)**
HR (bpm) 69.3 (12.5) 66.2 (8.3) 71.3 (15.0) 63.5 (8.2)
CO (ppm) 2.9 (1.0) 5.7 (0.7)*** 3.0 (0.7) 2.7 (0.8)
COHb (%) 1.1 (0.1) 1.5 (0.2)*** 1.1 (0.1) 1.1 (0.1)
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Figure 1. Schematic of protocol. fMRI tasks included breath holds (T1), visual stimulation (8Hz flashing 
checkerboard, T2) and a (right hand) finger tapping task (T3). Two sets of BOLD scans (each 10 min 6 s) 
were obtained on each experimental day, separated by a 5 min breathing intervention (air or CO, order 
randomized and counterbalanced) during which a structural scan was acquired. 
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Confidential: For Review Only
Figure 2. Exhaled CO (ppm). Baseline, post-scan (~20 min after end-inhalation) and 10 min post-scan (~30 
min after end-intervention). Individual values plus average and standard deviation (bold line). 
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C o nfi d e nti al: F or R e vi e w O nl yFi g u r e 3. B O L D f M R I r e s p o n s e a s s o ci a t e d wi t h b r e a t h - b y - b r e a t h e n d - ti d al C O 2 d u ri n g t h e b r e a t h h ol d t a s k.  W h ol e - b r ai n a n al y si s. I m a g e s a r e c ol o u r - r e n d e r e d s t a ti s ti c al m a p s ( Z s c o r e s ) s u p e ri m p o s e d o n a s t a n d a r d ( M N I ) b r ai n. Si g nifi c a n t r e gi o n s a r e di s pl a y e d wi t h a t h r e s h ol d of Z > 2. 3 wi t h a cl u s t e r p r o b a bili t y t h r e s h ol d 
of p < 0. 0 5 ( c o r r e c t e d f o r m ul ti pl e c o m p a ri s o n s ). M a p s a r e B O L D r e s p o n s e a s s o ci a t e d wi t h ai r a n d C O 
i n h al a ti o n ( p r e - a n d p o s t -i n t e r v e n ti o n ), p r e v e r s u s p o s t -i n t e r v e n ti o n diff e r e n c e m a p s f o r e a c h p r o t o c ol (  ),  
a n d c o n t r a s t s b e t w e e n p r o t o c ol s ( c o n t r a s t b e t w e e n t h e p r e - v e r s u s p o s t -i n t e r v e n ti o n diff e r e n c e m a p s ). F o r 
c o n t r a s t s, bl u e -li g h t bl u e i n di c a t e s w h e r e B O L D r e s p o n s e f oll o wi n g C O (i. e. C O ( p o s t > p r e ) ) w a s l o w e r t h a n 
B O L D r e s p o n s e f oll o wi n g ai r – i. e. o n t h e d a y t h e p a r ti ci p a n t s i n h al e d C O, t h e B O L D r e s p o n s e w a s r e d u c e d 
i n t h e p o s t -i n h al a ti o n s c a n, b u t t hi s di d n o t o c c u r o n t h e d a y t h e p a r ti ci p a n t s i n h al e d Ai r. T hi s diff e r e n c e 
b e t w e e n p r o t o c ol s w a s si g nifi c a n t. I n n o a r e a w a s B O L D r e s p o n s e f oll o wi n g C O i n c r e a s e d c o m p a r e d t o B O L D 
r e s p o n s e f oll o wi n g Ai r. A s h o w s a r e a s w h e r e c h a n g e i n B O L D f M R I r e s p o n s e f o r t h e C O p r o t o c ol c o r r el a t e s 
wi t h i n di vi d u al ri s e i n C O l e v el. R e d - y ell o w i n di c a t e s a p o si ti v e c o r r el a ti o n. 
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C o nfi d e nti al: F or R e vi e w O nl yFi g u r e 4. B O L D f M R I r e s p o n s e d u ri n g vi s u al s ti m ul u s. W h ol e - b r ai n a n al y si s. I m a g e s a r e c ol o u r - r e n d e r e d s t a ti s ti c al m a p s s u p e ri m p o s e d o n a s t a n d a r d ( M N I ) b r ai n. Si g nifi c a n t r e gi o n s a r e di s pl a y e d wi t h a t h r e s h ol d of Z > 2. 3 wi t h a cl u s t e r p r o b a bili t y t h r e s h ol d of p < 0. 0 5 ( c o r r e c t e d f o r m ul ti pl e c o m p a ri s o n s ). M a p s a r e B O L D 
r e s p o n s e a s s o ci a t e d wi t h ai r a n d C O i n h al a ti o n ( p r e - a n d p o s t -i n t e r v e n ti o n ), p r e v e r s u s p o s t -i n t e r v e n ti o n 
diff e r e n c e m a p s f o r e a c h p r o t o c ol (  ),  a n d c o n t r a s t s b e t w e e n p r o t o c ol s ( c o n t r a s t b e t w e e n t h e p r e - v e r s u s 
p o s t -i n t e r v e n ti o n diff e r e n c e m a p s ). F o r c o n t r a s t s, bl u e -li g h t bl u e i n di c a t e s w h e r e B O L D r e s p o n s e f oll o wi n g 
C O (i. e. C O ( p o s t > p r e ) ) w a s l o w e r t h a n B O L D r e s p o n s e f oll o wi n g ai r – i. e. o n t h e d a y t h e p a r ti ci p a n t s i n h al e d 
C O, t h e B O L D r e s p o n s e w a s r e d u c e d i n t h e p o s t -i n h al a ti o n s c a n, b u t t hi s di d n o t o c c u r o n t h e d a y t h e 
p a r ti ci p a n t s i n h al e d Ai r. T hi s diff e r e n c e b e t w e e n p r o t o c ol s w a s si g nifi c a n t. I n n o a r e a w a s ( C O ( p o s t > p r e ) ) 
g r e a t e r t h a n ( Ai r ( p o s t > p r e ). 
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C o nfi d e nti al: F or R e vi e w O nl yFi g u r e 5. B O L D f M R I r e s p o n s e d u ri n g m o t o r t a s k. W h ol e - b r ai n a n al y si s. I m a g e s a r e c ol o u r - r e n d e r e d s t a ti s ti c al m a p s s u p e ri m p o s e d o n a s t a n d a r d ( M N I ) b r ai n. Si g nifi c a n t r e gi o n s a r e di s pl a y e d wi t h a t h r e s h ol d of Z > 2. 3 wi t h a cl u s t e r p r o b a bili t y t h r e s h ol d of p < 0. 0 5 ( c o r r e c t e d f o r m ul ti pl e c o m p a ri s o n s ). M a p s a r e B O L D 
r e s p o n s e a s s o ci a t e d wi t h ai r a n d C O i n h al a ti o n ( p r e - a n d p o s t -i n t e r v e n ti o n ), p r e v e r s u s p o s t -i n t e r v e n ti o n 
diff e r e n c e m a p s f o r e a c h p r o t o c ol (  ),  a n d c o n t r a s t s b e t w e e n p r o t o c ol s ( c o n t r a s t b e t w e e n t h e p r e - v e r s u s 
p o s t -i n t e r v e n ti o n diff e r e n c e m a p s ). F o r c o n t r a s t s, bl u e -li g h t bl u e i n di c a t e s w h e r e t h e B O L D r e s p o n s e 
f oll o wi n g C O (i. e. C O ( p o s t > p r e ) ) w a s l o w e r t h a n t h e B O L D r e s p o n s e f oll o wi n g ai r a n d r e d - y ell o w i n di c a t e s 
w h e r e t h e B O L D r e s p o n s e f oll o wi n g C O w a s g r e a t e r t h a n t h e B O L D r e s p o n s e f oll o wi n g ai r. 
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